fertilizer

Ferring Pharmaceuticals has agreed to acquire Gameto, a startup developing next-generation in vitro fertilization treatments, in a deal worth up to $1.4 billion. The acquisition signals growing pharmaceutical interest in fertility care and advanced reproductive technologies, as the sector draws increasing investment amid rising demand for IVF and innovations aimed at improving success rates and reducing treatment burdens.

HZPC, a potato breeding company, is presenting research on precision nutrition as a way to make potato production more sustainable. The work focuses on matching nutrient inputs more closely to what crops actually need, aiming to reduce waste and environmental impact while maintaining yields. The topic is being reported in the potato and agricultural industry press as part of broader interest in sustainable farming methods.

Health coverage highlights how festival fasting can affect women's nutrition, hormonal balance and fertility, including for those undergoing IVF treatment. Doctors advise women to maintain adequate calorie, protein and micronutrient intake during fasting periods, stay hydrated, and consult a fertility specialist before combining prolonged fasts with hormone treatment or conception attempts.

New research finds only a small association between intelligence and family size, and one that depends heavily on context. Parenthood timing, education, family background and broader social conditions all shape the relationship, and completed-fertility and sibling studies complicate claims that higher intelligence consistently predicts having fewer or more children.

The Washington Post reports on an Iowa farmer who has scaled back operations as fuel, fertilizer and health care costs have surged. The piece illustrates how rising input prices and insurance expenses are squeezing farm budgets, forcing difficult trade-offs. It reflects a broader strain on US farmers as costs of production continue to outpace margins.

Agricultural extension experts have outlined the key chores homeowners should tackle this fall to ensure a healthy lawn and garden next spring. The seasonal guidance covers typical autumn tasks such as leaf cleanup, fertilizing, and preparing beds for winter. It is aimed at helping gardeners get ahead on maintenance before cold weather sets in.

Research reported by New Scientist suggests that ovaries transplanted into a recipient adapt to that person's biological age rather than keeping the age of the donor. The finding could influence fertility treatments and how scientists understand tissue ageing, prompting discussion among biologists and clinicians.

The Azot chemical plant in Russia's Tula region caught fire following a drone attack. The facility is one of the largest producers of nitrogen fertilizers in Russia and supplies nitric acid to the Sverdlov plant in Dzerzhinsk, which manufactures explosives. The strike is therefore being discussed in the context of its impact on Russia's military-industrial supply chain.

The Azot chemical plant in Novomoskovsk, Tula Oblast, came under attack and a fire broke out at the facility. Azot, part of the EuroChem Group, is one of Russia's largest nitrogen fertilizer producers, manufacturing ammonia and related products. Reports circulating online describe the blaze following the strike, with the plant's strategic role in fertilizer and chemical production drawing attention to the incident's possible impact.

A new study identifies the LRRC1 protein as linked to implantation failure, suggesting it may play a role in why embryos fail to attach to the uterine wall. The finding could point toward new research directions in fertility and reproductive medicine, though details of the study's methods and scope have not been widely reported yet.

Swiss biopharmaceutical company Ferring has agreed to acquire Gameto, a startup specializing in egg-freezing technology, in a deal worth $1.4 billion. Gameto has been developing treatments aimed at improving fertility preservation, making the acquisition a significant move in the fast-growing fertility treatment market. The transaction underscores growing pharmaceutical interest in reproductive health companies.

Swiss biopharmaceutical company Ferring has agreed to acquire Gameto, a startup focused on egg freezing and fertility treatments, in a deal worth $1.4 billion, according to Bloomberg News. The acquisition points to growing investment in reproductive health technology and could accelerate development of faster, lab-based egg-freezing methods for fertility patients.